Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

369.49 -7.97 (-2.11%)
Streaming Delayed Price Updated: 12:45 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stryker Stock Elevated To Top Tier Rating; Fresh Base Forming
Stryker also has a healthy B+ Accumulation/Distribution Rating, showing big investors like mutual funds are fairly heavy buyers of its stock. 
Via Investor's Business Daily
Looking Into Stryker's Recent Short Interest
Via Benzinga
The Latest Analyst Ratings for Stryker
Via Benzinga
Implants And Joint Replacement Company Stryker Tightens Annual Forecast On 'Positive Procedural Trends'
Stryker Corporation (NYSE: SYK) reported Q3 sales of $4.9 billion, up 9.6% Y/Y (+9.3% in constant currency), beating the consen 
Via Benzinga
Stryker Tumbles Despite Topping Sales, Earnings Expectations
Stryker stock tumbled late Thursday, though the company reported better-than-expected earnings and third-quarter sales. 
Via Investor's Business Daily
Stryker reports third quarter 2023 operating results
From Stryker Corporation
Via GlobeNewswire
$1000 Invested In Stryker 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Looking Into Stryker's Recent Short Interest
Via Benzinga
Expert Ratings for Stryker
Via Benzinga
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. 
Via Benzinga
Here's How Much You Would Have Made Owning Stryker Stock In The Last 20 Years
Via Benzinga
Why Stryker Stock Rose Today
Stryker Corporation (NYSE: SYK) shares traded higher on Monday. 
Via Benzinga
Stryker to participate in the 6th Annual Evercore ISI HealthCONx Conference
From Stryker Corporation
Via GlobeNewswire
IBD's 100 Best ESG Companies For 2023
The companies on our list combine high sustainability scores and top stock ratings. 
Via Investor's Business Daily
What's Going On With Stryker Stock?
Stryker Corp (NYSE: SYK) shares are trading lower by 1.4% to $256.46 Thursday morning. 
Via Benzinga
How Is The Market Feeling About Stryker?
Via Benzinga
The Value Deepens for Medtech Stocks: Reversal Imminent
MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows. 
Via MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Here's How Much You Would Have Made Owning Stryker Stock In The Last 20 Years
Via Benzinga
Looking At Stryker's Recent Unusual Options Activity
Via Benzinga
Peering Into Stryker's Recent Short Interest
Via Benzinga
The Pros Got It Wrong: 3 Stocks to Sell Despite Recent Upgrades
These three stocks to sell may be good picks for nimble traders, but for long-term investors, it may be time to put them aside. 
Via InvestorPlace
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
These three top-notch stocks would make great additions to any dividend portfolio. 
Via The Motley Fool
Over 2,400 Surgical Cases Completed Using Stryker’s Q Guidance System with Spine Guidance Software in First Year
From Stryker
Via Business Wire
Why Stryker (SYK) Stock Fell 5% Wednesday
Stryker Corp (NYSE: SYK) shares fell 5.26% to $260.05 Wednesday. The stock experienced weakness after the FDA established a Digital Health Advisory Committee. 
Via Benzinga
Exposures Product Safety
Stryker to host investor day
From Stryker Corporation
Via GlobeNewswire
Stryker to announce financial results for its third quarter of fiscal year 2023
From Stryker Corporation
Via GlobeNewswire
Three Of Our Top Picks For Your Healthcare Portfolio
Amidst macro uncertainty, healthcare stocks should outperform. 
Via Talk Markets
Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions
From Stryker
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.